FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056150781> ?p ?o ?g. }

• W2056150781 abstract "Background: Prostate cancer (PC) is the most common cause of cancer death in men. In advanced PC, many patients suffer chemo-resistance therefore; establishment of a drug-resistant cell model to study the mechanism of action of drug resistance and increase in drug sensitivity is urgently needed. Recently, cancer stem cells (CSCs), and epithelial mesenchymal transition (EMT) have been suggested to play important roles in drug resistance in various cancer types. Green tea polyphenols, particularly the major component epigallocatechin-3-gallate (EGCG), have been shown to have chemopreventive properties in the malignant setting and recent studies have suggested that green tea catechins may enhance the chemo-sensitivity of drug-resistant cancer cells, such as breast cancer, although the mechanism of action is still unclear. Aims: (1) To establish a multi-drug-resistant prostate cancer cell line enriched for CSCs and (2) To investigate whether EGCG can restore drug sensitivity by limiting CSC expansion and/or by reversal of EMT. Experimental procedures: Chemo-resistant (CR) PC3M cells were developed by growth in increasing concentrations of a chemotherapeutic agent. Drug resistance was confirmed using increasing concentrations of doxorubicin (Dox), Taxotere (Tax), 5-fluorouracil (5FU) and cisplatin in fluorometric cell viability assays on resistant and wild-type (WT) cells. Immunofluorescent (IF) staining and flow cytometry were used to identify CSCs. Gene expression was assessed using quantitative real time-PCR. Cell morphology was observed using Nikon invert microscopy. Results: A chemo-resistant variant of WT-PC3M was derived by long-term culture in increasing concentrations of the chemotherapeutic, 5FU. As a result, the IC50 for WT PC3M to 5FU was 30μM as compared to >500μM for CR PC3M. In addition, the CR cells were also shown to be resistant to other chemotherapeutics including Dox and Tax, but not cisplatin. Enrichment for cells with CSC properties was determined in WT and CR cells. In comparison to WT PC3M, gene expression of both CD133 and ATP-binding cassette subfamily G2 (ABCG2), which have been reported as CSC markers in various cancer including prostate cancer, were significantly up-regulated by 10 and 2-folds, respectively in drug resistant cells (p When EGCG was combined with 5FU, the IC50 of 5FU in CR PC3M decreased from 500μM to 100μM in CR PC3M, but it did not show a significant effect in WT PC3M, suggesting that EGCG had restored drug sensitivity in CR cells. It was noted that chemo-resistant PC3M had a more mesenchymal appearance when compared to WT PC3M. The expression of key EMT transcriptional regulator genes such as twist, snail, slug and zeb-1, were up-regulated whereas the epithelial marker gene E-cadherin was down-regulated in CR PC3M. After 48hours treatment with EGCG, all four EMT regulatory genes were significantly down-regulated by up to 3-folds whereas expression of E-cadherin was elevated. Conclusion: Green tea polyphenols restore drug sensitivity in chemo-resistant prostate cancer by reversal of EMT. Citation Information: Clin Cancer Res 2010;16(7 Suppl):A21" @default.
• W2056150781 created "2016-06-24" @default.
• W2056150781 creator A5033723598 @default.
• W2056150781 creator A5046244920 @default.
• W2056150781 creator A5058728431 @default.
• W2056150781 creator A5073293416 @default.
• W2056150781 creator A5083898904 @default.
• W2056150781 date "2010-04-01" @default.
• W2056150781 modified "2023-09-25" @default.
• W2056150781 title "Abstract A21: Cancer stem cell in multi-drug-resistant prostate cancer and green tea polyphenols restore drug sensitivity by reversal of epithelial mesenchymal transition" @default.
• W2056150781 doi "https://doi.org/10.1158/1078-0432.tcme10-a21" @default.
• W2056150781 hasPublicationYear "2010" @default.
• W2056150781 type Work @default.
• W2056150781 sameAs 2056150781 @default.
• W2056150781 citedByCount "0" @default.
• W2056150781 crossrefType "proceedings-article" @default.
• W2056150781 hasAuthorship W2056150781A5033723598 @default.
• W2056150781 hasAuthorship W2056150781A5046244920 @default.
• W2056150781 hasAuthorship W2056150781A5058728431 @default.
• W2056150781 hasAuthorship W2056150781A5073293416 @default.
• W2056150781 hasAuthorship W2056150781A5083898904 @default.
• W2056150781 hasConcept C114851261 @default.
• W2056150781 hasConcept C121608353 @default.
• W2056150781 hasConcept C126322002 @default.
• W2056150781 hasConcept C2776694085 @default.
• W2056150781 hasConcept C2778239845 @default.
• W2056150781 hasConcept C2779013556 @default.
• W2056150781 hasConcept C2780192828 @default.
• W2056150781 hasConcept C2781303535 @default.
• W2056150781 hasConcept C28328180 @default.
• W2056150781 hasConcept C502942594 @default.
• W2056150781 hasConcept C55427017 @default.
• W2056150781 hasConcept C71924100 @default.
• W2056150781 hasConcept C76419328 @default.
• W2056150781 hasConcept C86803240 @default.
• W2056150781 hasConcept C89423630 @default.
• W2056150781 hasConcept C95444343 @default.
• W2056150781 hasConcept C96232424 @default.
• W2056150781 hasConcept C98274493 @default.
• W2056150781 hasConceptScore W2056150781C114851261 @default.
• W2056150781 hasConceptScore W2056150781C121608353 @default.
• W2056150781 hasConceptScore W2056150781C126322002 @default.
• W2056150781 hasConceptScore W2056150781C2776694085 @default.
• W2056150781 hasConceptScore W2056150781C2778239845 @default.
• W2056150781 hasConceptScore W2056150781C2779013556 @default.
• W2056150781 hasConceptScore W2056150781C2780192828 @default.
• W2056150781 hasConceptScore W2056150781C2781303535 @default.
• W2056150781 hasConceptScore W2056150781C28328180 @default.
• W2056150781 hasConceptScore W2056150781C502942594 @default.
• W2056150781 hasConceptScore W2056150781C55427017 @default.
• W2056150781 hasConceptScore W2056150781C71924100 @default.
• W2056150781 hasConceptScore W2056150781C76419328 @default.
• W2056150781 hasConceptScore W2056150781C86803240 @default.
• W2056150781 hasConceptScore W2056150781C89423630 @default.
• W2056150781 hasConceptScore W2056150781C95444343 @default.
• W2056150781 hasConceptScore W2056150781C96232424 @default.
• W2056150781 hasConceptScore W2056150781C98274493 @default.
• W2056150781 hasLocation W20561507811 @default.
• W2056150781 hasOpenAccess W2056150781 @default.
• W2056150781 hasPrimaryLocation W20561507811 @default.
• W2056150781 hasRelatedWork W1993407183 @default.
• W2056150781 hasRelatedWork W2002781339 @default.
• W2056150781 hasRelatedWork W2022436212 @default.
• W2056150781 hasRelatedWork W2027378805 @default.
• W2056150781 hasRelatedWork W2211969368 @default.
• W2056150781 hasRelatedWork W2253181003 @default.
• W2056150781 hasRelatedWork W2263621505 @default.
• W2056150781 hasRelatedWork W2525994368 @default.
• W2056150781 hasRelatedWork W2552820307 @default.
• W2056150781 hasRelatedWork W2566780377 @default.
• W2056150781 hasRelatedWork W2572109314 @default.
• W2056150781 hasRelatedWork W2622281185 @default.
• W2056150781 hasRelatedWork W2739851985 @default.
• W2056150781 hasRelatedWork W2894953910 @default.
• W2056150781 hasRelatedWork W2907398425 @default.
• W2056150781 hasRelatedWork W2912950397 @default.
• W2056150781 hasRelatedWork W2940444617 @default.
• W2056150781 hasRelatedWork W3009139296 @default.
• W2056150781 hasRelatedWork W3047397125 @default.
• W2056150781 hasRelatedWork W3203070617 @default.
• W2056150781 isParatext "false" @default.
• W2056150781 isRetracted "false" @default.
• W2056150781 magId "2056150781" @default.
• W2056150781 workType "article" @default.